Cardiac Drug Therapy

ISBN-13: 9781617799617 / Angielski / Miękka / 2014 / 791 str.

M. Gabriel Khan

Opis

This book is an essential guide to the medical treatment of the cardiac patient and presents core principles of cardiovascular therapeutics as well as drug recommendations. Major classes of drugs are featured, including beta-blockers, ACE inhibitors, calcium antagonists, diuretics, and antiplatelet agents and unique insights into the controversies surrounding the use of specific drugs are explored, with answers given to the question: do beta blockers and diuretics really cause diabetes? Properties, dosage, side effects, potential salutary benefits, and drawbacks on virtually all commercially available cardiac drugs are examined. This revised edition is thoroughly updated and addresses the entire spectrum of heart disorders, such as hypertension, angina, myocardial infarction, heart failure, arrhythmias, cardiac arrest, and dyslipidemias. New chapters include endocrine heart diseases, management of cardiomyopathies, and newer agents. In addition, topics such as cardiac drugs in pregnancy and lactation and drug interactions are covered. Cardiac Drug Therapy, Eighth Edition, is an authoritative and clinically relevant resource for cardiologists, cardiology fellows, and internists.

Recenzje

From the book reviews:

"This excellent book serves as a complete guide to therapeutic strategies for patients with cardiac diseases. ... This is an excellent guide for any practitioner prescribing cardiac medications, including medical students, residents, fellows, general practitioners, and consultants. ... This is a quick and easy read, presenting comprehensive and up-to-date information. ... This book is well written and suitable for those at various levels of training involved in prescribing cardiac medications." (Parham Parto, Doody's Book Reviews, February, 2015)

Spis treści

1.     Beta-Blockers: The Cornerstone of Cardiac Drug Therapy

2.     Beta-Blocker Controversies

3.     Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

4.     ACE Inhibitor Controversies

5.     Calcium Antagonists (Calcium Channel Blockers)

6.     Calcium Antagonist Controversies

7.     Diuretics

8.     Hypertension

9.     Hypertension Controversies

10.  Angina

11.  Acute Myocardial Infarction

12.  Heart Failure

13.  Heart Failure Controversies

14.  Management of Cardiac Arrhythmias

15.  Cardiac Arrest

16.  Management of Infective Endocarditis

17.  Dyslipidemias

18.  Endocrine Heart Diseases

19.  Antiplatelet Agents, Anticoagulants, Factor XA Inhibitors, Thrombin Inhibitors

20.  Cardiac Drugs During Pregnancy and Lactation

21.  Effects of Drug Interactions

22.  Hallmark Clinical Trials

23.  Management of Cardiomyopathies

24.  Newer Agents

O autorze

Dr. M. Gabriel Khan is a cardiologist at the Ottawa Hospital and an Associate Profes­sor of Medicine, at the University of Ottawa. Dr. Khan graduated MB, BCh, with First-Class Honours at The Queen’s University of Belfast. He obtained , by thesis, the Degree  of  Doctor of Medicine  with  Honours ( QUB). He is the author of Encyclopedia of Heart Diseases, Academic Press/ Elsevier, 2006; Encyclopedia of Heart Diseases,  2^nd ed., Springer Science+Business Media,  2011; Rapid ECG Interpretation, 3^rd ed.,  Humana Press/Springer Science+Business Media, 2008;  On Call Cardiology, 3^rd  ed., Elsevier, 2006; Heart Disease Diagnosis and Therapy, 2^nd ed., Humana Press, 2006; Cardiac and Pulmonary Management (1993); Medical Diagnosis and Therapy (1994); Heart Attacks, Hypertension and Heart Drugs (1986); and Heart Trouble Encyclopedia (1996).